P. Bagatella

发表

Anti-β2-Glycoprotein I Antibodies in Patients with Acute Venous Thromboembolism

Paolo Prandoni, Antonio Girolami, P. Prandoni, 1999 .

The Diagnostic Value of Compression Ultrasonography in Patients with Suspected Recurrent Deep Vein Thrombosis

P. Prandoni, E. Bernardi, A. Girolami, 2002, Thrombosis and Haemostasis.

Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism

M. Prins, P. Prandoni, E. Bernardi, 2002, Annals of Internal Medicine.

Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy.

A. Ruffatti, V. Pengo, A. Cavazzana, 2009, Thrombosis research.

The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study

M. Prins, P. Prandoni, E. Bernardi, 2004, BMJ : British Medical Journal.

The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.

P. Prandoni, E. Bernardi, P. Simioni, 1997, Haematologica.

Warfarin Optimal Duration Italian Trial Investigators. Three months versus one year of oral anticoagulant therapy for idiopatic deep venous thrombosis.

W. Ageno, A. Iorio, P. Prandoni, 2001 .

The Utility of Non-invasive Tests for Detection of Previous Proximal-vein Thrombosis

P. Prandoni, E. Bernardi, A. Cogo, 1995, Thrombosis and Haemostasis.

Which Is the Outcome of the Post-thrombotic Syndrome?

M. Prins, P. Prandoni, A. Girolami, 1999, Thrombosis and Haemostasis.

Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism.

P. Prandoni, A. Girolami, E. Zanon, 1999, Thrombosis research.

Venous thromboses of upper limbs are more frequently associated with occult cancer as compared with those of lower limbs.

P. Prandoni, A. Girolami, E. Zanon, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Reduced Mobilisation of Hematopoietic Stem Cells After Hepatic Resection for Malignant Liver Disease

P. Marson, P. Bagatella, C. Donadel, 2008, Pathology & Oncology Research.

Virus-inactivated plasma - Plasmasafe: a one-year experience.

P. Carraro, G. De Silvestro, T. Tison, 2007, Blood transfusion = Trasfusione del sangue.

Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.

W. Ageno, M. Bazzan, A. Iorio, 2001, The New England journal of medicine.

The Italian registry of pediatric therapeutic apheresis: A report on activity during 2005

P. Marson, G. De Silvestro, C. Stefanutti, 2009, Journal of clinical apheresis.

The Italian Sidem Registry for Apheresis: An Overview of the 2005 Statistics

P. Marson, G. De Silvestro, T. Tison, 2008, The International journal of artificial organs.

Use of an Algorithm for Administering Subcutaneous Heparin in the Treatment of Deep Venous Thrombosis

P. Prandoni, E. Bernardi, A. Girolami, 1998, Annals of Internal Medicine.

Plasma exchange for the management of the catastrophic antiphospholipid syndrome: importance of the type of fluid replacement

F. Fabris, A. Ruffatti, P. Marson, 2008, Journal of internal medicine.

Local versus Central Assessment of Venographies in a Multicenter Trial on the Prevention of Deep Vein Thrombosis in Neurosurgery

G. Agnelli, E. Giugni, P. Bagatella, 1999, Thrombosis and Haemostasis.

Postthrombotic Syndrome: Incidence, Prevention, and Management

P. Prandoni, E. Bernardi, P. Simioni, 2001, Seminars in vascular medicine.

Low Rate of Warfarin-related Major Bleeding in Patients with Recurrent Venous Thromboembolism

P. Prandoni, P. Simioni, A. Girolami, 1999, Thrombosis and Haemostasis.

Ultrasonography of contralateral veins in patients with unilateral deep-vein thrombosis

P. Prandoni, A. Girolami, A. Piccioli, 1998, The Lancet.